Frazier — Full Portfolio

3 tracked investments · listed companies and verified rows first

Angitia Bio is a biopharmaceutical company developing therapies for musculoskeletal and related diseases.

Biotech

Co-investorsAscenta Capital Frazier Life Sciences OrbiMed RA Capital Wellington Management

Golden State Medical Supplygsms.us inApr 2019acquired by Court Square Capital Partners

A pharmaceutical company that markets a portfolio of drug products across various dosage forms, with labeling and packaging following FDA requirements.

Advanced ManufacturingBiotechHealthtechLogistics & Supply Chain

Rick Ryan(Executive Director and Founder, WSI)Benjamin Hall(Chief Executive Officer)in David Arnold(President/Chief Operating Officer)in Sonia De La Rosa(Chief Commercial Officer, Corporate Development and Strategy)in

Co-investorsFrazier Healthcare Partners Fulcrum Equity Partners New Enterprise Associates (NEA)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Nexcida Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.